SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 184.82-1.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (25857)9/29/1998 7:22:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
Bear Stearns reiterated a BUY this afternoon and offered some hints on a BUYOUT. Here's the summary of the reiterated BUY:
LGND: Ligand Enters into Significant Strategic Alliance with Elan
Bear Stearns & Co. Inc.
D Molowa,E Lovell
September 29, 1998

David T. Molowa, Ph.D. (212) 272-2722 9/29/98
Ethan T. Lovell (212) 272-9098
Alan P. Meyers (212) 272-6637

Subject: Company Update
Industry: Biotechnology

BEAR, STEARNS & CO. INC.

Ligand Pharmaceuticals (LGND - 11 «) - Buy

Ligand Enters into Significant Strategic Alliance with Elan
_________________________________________________________________
*** Deal provides near-term financing ($50 million) to
commercialize first two products and comfortably fund the
operations of the company.

*** Deal provides access to capital ($80 million) for
opportunistic in-licensing/acquisition activity.

*** Ligand acquires rights to a Phase III product that could be
launched in 2000.
_________________________________________________________________

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext